发明授权
- 专利标题： Selective inhibitors of ERK protein kinase and uses thereof
- 专利标题（中）： ERK蛋白激酶的选择性抑制剂及其用途
-
申请号： US11312618申请日： 2005-12-20
-
公开(公告)号： US07501415B2公开(公告)日： 2009-03-10
- 发明人: Alexander Aronov , Michael Hale , Francois Maltais , Gabriel Martinez-Botella , Judith Straub , Qing Tang
- 申请人： Alexander Aronov , Michael Hale , Francois Maltais , Gabriel Martinez-Botella , Judith Straub , Qing Tang
- 申请人地址： US MA Cambridge
- 专利权人： Vertex Pharmaceuticals Incorporated
- 当前专利权人： Vertex Pharmaceuticals Incorporated
- 当前专利权人地址： US MA Cambridge
- 代理商 Daniel A. Pearson
- 主分类号： C07D403/04
- IPC分类号： C07D403/04 ; A61K31/506
摘要：
Described herein are compounds that are useful as ERK2 inhibitors. These compounds, and pharmaceutically acceptable compositions thereof, are useful for treating or lessening the severity of a variety of disorders, including proliferative disorders such as cancer.
公开/授权文献
信息查询
